Evidence map›Paper›PMID 31561445›Full record

ReviewMolecules (Basel, Switzerland)2019

Novel Antiretroviral Structures from Marine Organisms.

Karlo Wittine, Lara Saftić, Željka Peršurić, Sandra Kraljević Pavelić

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karlo WittineUniversity of Rijeka, Department of Biotechnology, Centre for high-throughput technologies, Radmile Matejčić 2, 51000 Rijeka, Croatia. karlo.wittine@biotech.uniri.hr.ORCID 0000-0002-0936-6709
Lara SaftićUniversity of Rijeka, Department of Biotechnology, Centre for high-throughput technologies, Radmile Matejčić 2, 51000 Rijeka, Croatia. lara.saftic@gmail.com.
Željka PeršurićUniversity of Rijeka, Department of Biotechnology, Centre for high-throughput technologies, Radmile Matejčić 2, 51000 Rijeka, Croatia.ORCID 0000-0003-0045-1269
Sandra Kraljević PavelićUniversity of Rijeka, Department of Biotechnology, Centre for high-throughput technologies, Radmile Matejčić 2, 51000 Rijeka, Croatia. sandrakp@biotech.uniri.hr.ORCID 0000-0003-0491-673X
University of Rijeka · HR

Funding

Croatian governement and European Regional Development Fund (ERDF) : Research Infrastructure for Campus-based Laboratories at University of Rijeka University of Rijeka uniri-biomed-18-133 (1277)Croatian Government and European Union (European Regional Development Fund-the Competitiveness and Cohesion Operational Programme - KK.01.1.1.01) KK.01.1.1.01.0002
6 · The paper itself

Abstract

In spite of significant advancements and success in antiretroviral therapies directed against HIV infection, there is no cure for HIV, which scan persist in a human body in its latent form and become reactivated under favorable conditions. Therefore, novel antiretroviral drugs with different modes of actions are still a major focus for researchers. In particular, novel lead structures are being sought from natural sources. So far, a number of compounds from marine organisms have been identified as promising therapeutics for HIV infection. Therefore, in this paper, we provide an overview of marine natural products that were first identified in the period between 2013 and 2018 that could be potentially used, or further optimized, as novel antiretroviral agents. This pipeline includes the systematization of antiretroviral activities for several categories of marine structures including chitosan and its derivatives, sulfated polysaccharides, lectins, bromotyrosine derivatives, peptides, alkaloids, diterpenes, phlorotannins, and xanthones as well as adjuvants to the HAART therapy such as fish oil. We critically discuss the structures and activities of the most promising new marine anti-HIV compounds.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsAquatic OrganismsBiological ProductsDrug DevelopmentFish OilsHIV-1HumansStructure-Activity RelationshipAnti-HIV AgentsAnti-Retroviral AgentsBiological ProductsFish Oilsanti-HIVantiretroviral agentsdrug developmentmarine metabolitesnatural products

Identifiers

PMID31561445
PMCPMC6804230
OpenAlexW2975008636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.